According to the Atlanta-based Centers for Disease Control and Prevention, the type of flu vaccine and number of doses needed ...

Previously, the COVID-19 immunizations made by Pfizer and Moderna were the only mRNA vaccines on the market.

The shot, made by Moderna, will be available for this year's upcoming flu season.

The FDA's approval of an mRNA flu shot presents a new, long-awaited option—and raises big questions about the future of flu ...

Moderna, the biotechnology company that rose to prominence with one of the first messenger RNA vaccines against COVID-19, has ...

A new mRNA flu vaccine showed a 27% reduction in flu cases in a clinical trial, but its path to FDA approval faced an early regulatory setback.

Key Takeaway: The FDA’s approval of mFLUSIVA may indicate increased commercial and strategic value of mRNA vaccine patents. On August 5, 2026, Moderna announced that the U.S. Food and Drug ...

Takeda’s oveporexton (Orzeyful), a selective OX2R agonist, is the first therapy targeting orexin deficiency in NT1, improving ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA on Aug. 5, 2026 approved a new mRNA-based flu vaccine. (Melissa Phillip/AP) After months of regulatory questioning, the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration headquarters is shown in Silver Spring, Md. The FDA has approved a new flu vaccine for ...